Mondelez is a publicly traded company in the Consumer sector. This company operates across Consumer and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 4 active Congressional signals mentioning Mondelez, including 4 bills. The current legislative sentiment leans bearish, with regulatory or policy headwinds potentially affecting performance.
The Protecting Children with Food Allergies Act of 2025 mandates annual food allergy training for school food service personnel, creating a new regulatory requirement for school nutrition programs. This directly increases demand for allergy-related educational materials and services, benefiting companies providing food safety training and allergen-free food products. Food service distributors and manufacturers will adapt menus and training.
Impact: 4/10(Early stage (action not classified))S1469Congressional Bill
The PACK Act imposes stringent new requirements on consumer product packaging claims regarding recyclability and compostability, directly increasing compliance costs for consumer goods manufacturers. Companies must now verify and qualify all such claims, or face Federal Trade Commission enforcement. This bill creates a new regulatory burden for companies across the consumer packaged goods sector.
HR7945 bans the sale of nitrous oxide consumer products, directly eliminating a revenue stream for companies producing or distributing these items. This creates an immediate regulatory hurdle for food and beverage manufacturers utilizing nitrous oxide as a propellant or additive. Affected companies must reformulate products or exit the market segment.
Impact: 9/10(Signed into law)HR7945Congressional Bill
The Childhood Diabetes Reduction Act of 2025 mandates health warning labels on sugar-sweetened beverages, non-sugar sweetened foods, and ultra-processed foods, and restricts advertising to children. This directly impacts major food and beverage manufacturers by increasing operational costs and potentially reducing sales volumes. The bill's referral to committee and limited sponsorship indicate a moderate, not immediate, market impact.